Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
15.93
+0.13 (0.82%)
At close: Aug 1, 2025, 4:00 PM
16.00
+0.07 (0.44%)
After-hours: Aug 1, 2025, 7:01 PM EDT

Arrowhead Pharmaceuticals Stock Forecast

Stock Price Forecast

The 7 analysts that cover Arrowhead Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $43.71, which forecasts a 174.39% increase in the stock price over the next year. The lowest target is $17 and the highest is $80.

Price Target: $43.71 (+174.39%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$17$43.71$42$80
Change+6.72%+174.39%+163.65%+402.20%
* Price targets were last updated on May 20, 2025.

Analyst Ratings

The average analyst rating for Arrowhead Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy333333
Buy444443
Hold444332
Sell000000
Strong Sell000000
Total11111110108

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong BuyReiterates$80+402.20%May 20, 2025
Citigroup
Citigroup
Hold
Maintains
$21$17
HoldMaintains$21$17+6.72%May 13, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$60
Strong BuyMaintains$60+276.65%May 13, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Reiterates
$51$38
Strong BuyReiterates$51$38+138.54%Feb 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$80
Strong BuyReiterates$80+402.20%Feb 12, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
798.44M
from 3.55M
Increased by 22,384.93%
Revenue Next Year
319.07M
from 798.44M
Decreased by -60.04%
EPS This Year
0.04
from -5.00
EPS Next Year
-3.43
from 0.04
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingSep 30, 2020Sep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026Sep 30, 2027
Revenue
87.99M138.29M243.23M240.74M3.55M798.44M319.07M373.27M
Revenue Growth
-47.87%57.16%75.89%-1.03%-98.53%22,384.93%-60.04%16.99%
EPS
-0.84-1.36-1.67-1.92-5.000.04-3.43-3.68
EPS Growth
--------
Forward PE
-----376.69--
No. Analysts
-----181812
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High960.2M490.3M564.0M
Avg798.4M319.1M373.3M
Low652.0M157.8M262.6M

Revenue Growth

Revenue Growth20252026202720282029
High
26,941.1%
-38.6%
76.8%
Avg
22,384.9%
-60.0%
17.0%
Low
18,261.6%
-80.2%
-17.7%

EPS Forecast

EPS20252026202720282029
High1.65-1.74-0.71
Avg0.04-3.43-3.68
Low-1.24-4.63-5.65

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.